Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease III: Clinical Manifestations and Complications01:25

Peptic Ulcer Disease III: Clinical Manifestations and Complications

Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant use.Gastric UlcersGastric ulcers share...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert Clinical Consensus on Body Surface Gastric Mapping Phenotypes for Gastroduodenal Disorders: 'Auckland Classification' v1.0.

Neurogastroenterology and motility·2026
Same author

Effect of icosapent ethyl treatment on colorectal tissue marine omega-3 polyunsaturated fatty acid levels among patients with a history of adenoma: a prospective, single-arm clinical trial.

The American journal of clinical nutrition·2026
Same author

A Multicenter, Sham-Controlled, Pilot, Randomized Controlled Trial of Interferential Therapy for the Treatment of Chronic Constipation.

Journal of clinical gastroenterology·2026
Same author

Avoidant/Restrictive Food Intake Disorder Is Common in Adult and Pediatric Patients with Celiac Disease and Non-Celiac Gluten Sensitivity.

Nutrients·2026
Same author

Randomized Sham-Controlled Trial of Translumbosacral Neuromodulation Therapy for Fecal Incontinence.

Gastroenterology·2026
Same author

The Management of Irritable Bowel Syndrome: A Position Paper of the Neurogastroenterology and Motility Section of the Israeli Gastroenterology Association.

Journal of clinical gastroenterology·2026
Same journal

Comment on: Continuous versus intermittent anticoagulation during endoscopic treatment of esophageal varices in cirrhosis: a randomized controlled trial.

Therapeutic advances in gastroenterology·2026
Same journal

Upadacitinib for anti-TNFα refractory immune checkpoint inhibitor-induced colitis: a case report.

Therapeutic advances in gastroenterology·2026
Same journal

International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease.

Therapeutic advances in gastroenterology·2026
Same journal

Age-stratified colonoscopy outcomes and referral-factor associations in the Swedish colorectal cancer fast-track pathway: a retrospective cohort study.

Therapeutic advances in gastroenterology·2026
Same journal

The role of enteroscopy in the diagnosis and interventional management of small intestine diseases.

Therapeutic advances in gastroenterology·2026
Same journal

Impact of wet suction on specimen quality and diagnostic accuracy in EUS-guided tissue acquisition: a systematic review and meta-analysis of randomized controlled trials.

Therapeutic advances in gastroenterology·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Functional dyspepsia.

Rita Brun1, Braden Kuo

  • 1GI-Unit, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.

Therapeutic Advances in Gastroenterology
|December 25, 2010
PubMed
Summary
This summary is machine-generated.

Functional dyspepsia (FD) affects many worldwide, impacting quality of life. Research explores its complex causes, including gut-brain interactions, and limited but evolving treatments.

Keywords:
drug therapyfunctional dyspepsiagastric motilityvisceral hypersensitivity

More Related Videos

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

Related Experiment Videos

Last Updated: Jun 5, 2026

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
06:40

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management

Published on: June 29, 2019

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
06:46

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring

Published on: December 14, 2020

Area of Science:

  • Gastroenterology
  • Digestive Health
  • Clinical Medicine

Background:

  • Functional dyspepsia (FD) is a prevalent condition characterized by a range of abdominal symptoms.
  • The Rome III criteria (2006) defined FD and its subtypes: postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS).
  • FD significantly impacts patients' quality of life globally.

Purpose of the Study:

  • To review the current understanding of functional dyspepsia (FD).
  • To explore the pathophysiology, diagnostic approaches, and therapeutic options for FD.

Main Methods:

  • Review of existing literature on functional dyspepsia (FD).
  • Analysis of diagnostic criteria and pathophysiological mechanisms.
  • Evaluation of current and emerging treatment strategies.

Main Results:

  • FD is a common disorder with diverse underlying mechanisms, including abnormal gastric emptying, visceral hypersensitivity, impaired gastric accommodation, and central nervous system factors.
  • Diagnostic tests can assess physiological functions relevant to FD pathogenesis.
  • Pharmacological treatments for FD are limited but include prokinetics, antidepressants (SSRIs, TCAs), and proton-pump inhibitors (PPIs), with accumulated experience in their use.

Conclusions:

  • The heterogeneous nature of FD, resulting from combined physiological and central nervous system alterations, suggests that tailored, combined therapeutic approaches may be most beneficial.
  • Further research into the complex pathophysiology of FD is needed to develop more effective treatments.